Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Warning:

This document is being maintained for historical purposes, but is now out of date. To view current guidelines please visit:


1993 Sexually Transmitted Diseases Treatment Guidelines


09/24/1993

SUGGESTED CITATION
Centers for Disease Control and Prevention. 1993 Sexually
transmitted diseases treatment guidelines. MMWR 1993;42(No. RR-14):
{inclusive page numbers}.

CIO Responsible for this publication:
National Center for Prevention Services,
Division of Sexually Transmitted Diseases and HIV Prevention

References

1. CDC. Sexually Transmitted Diseases Clinical Practice Guidelines, 1991. 2. CDC. Technical guidance on HIV counseling. MMWR 1993;42(RR-2):8- 17. 3. American Academy of Pediatrics, American College of Obstetrics and Gynecology (ACOG). Guidelines for Perinatal Care, third edition, 1992. 4. Guide to Clinical Preventive Services, Report of the U.S. Preventive Services Task Force. Williams and Wilkins:Baltimore, MD., 1989. 5. CDC. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR 1993;42(RR-12):1-39. 6. CDC. Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR 1992;41(RR-12):1-9. 7. CDC. Purified protein derivative (PPD-tuberculin anergy) and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40 (RR-5):27-33. 8. CDC. The use of preventive therapy for tuberculous infection in the United States. MMWR 1990;39(RR-8):6-8. 9. CDC. Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992;41(RR-11):59-71. 10. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 1993;42(RR-4):1-18. 11. CDC. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR 1992;41(RR-4):1-11. 12. CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991;40(RR-2):1-13. 13. Committee on Infectious Diseases, American Academy of Pediatrics. Report of the Committee on Infectious Diseases, 22nd edition, 1991. 14. Beall GN. Penicillins. In: Saxon A, moderator. Immediate hypersensitivity reactions to beta lactam antibiotics. Ann Intern Med 1987;107:204-15. 15. Oral desensitization protocol for patients with a positive skin test Table 1. N Engl J Med 1985:312;1229-32. 16. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4. 17. CDC. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination, Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1991;40(RR-13):1-25.



This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.
TOP